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Metastatic melanoma is an aggressive disease that can spread to many organs of the body. In rare cases, it can spread to the
gallbladder causing secondary lesions, yet presenting with little to no symptoms. Therefore, most cases of metastatic melanoma
lesions to the gallbladder go undiagnosed. Here, we present the case of a 41-year-oldmale with a four-month history ofmelanoma of
the face, with a postresection status, who presented with right upper quadrant abdominal pain. Doppler ultrasound and computed
tomography confirmed the presence of a mass on the gallbladder. Laparoscopic excision along with liver wedge resection was
performed. Pathology staining revealed the presence of a malignant metastatic melanoma lesion of the gallbladder.
1. Introduction
Cutaneous melanoma is a very aggressive disease, arising
from the proliferation of melanocytes, a type of dendritic
cell found in the epidermis, uvea, meninges, intestinal tract,
upper respiratory tract, and along regional lymph nodes [1–
3]. While it comprises less than 5% of all skin cancer cases,
it has an extremely high morbidity and mortality due to
its high tendency to metastasize throughout the body [1–4].
The most common sites of distant metastases are the lungs,
brain, liver, and GI tract [1–3]. Only 2–4% of patients affected
by cutaneous melanoma are diagnosed with gastrointestinal
metastases and the most common sites are the small bowel,
colon, and stomach [1, 2]. Metastatic involvement of the gall-
bladder is extremely rare and, when present, is often part of a
widespread complex ofmetastases with a very poor prognosis
[1, 4, 5]. Interestingly, autopsy reports suggest gallbladder
involvement in 4–20% of all cutaneous melanoma metastasis
patients; however, they are associated with minimal to no
symptoms, making diagnosis difficult during its lifetime [5–
7].
Here, we report a rare case of melanomametastasis to the
gallbladder as the first site of recurrence following cutaneous
melanoma treatment. The patient presented with right upper
quadrant abdominal pain and was successfully treated with
cholecystectomy and liver wedge resection surgery.
2. Case Report
Written consent for publication of this case was obtained
from the patient. We present a 41-year-old male with a
medical history of cutaneous melanoma of the face who
presented to the hospital with abdominal pain.Three months
prior to this admission, the patient was diagnosed with an
ulcerated nodular malignant melanoma of his right temple,
Breslow thickness 12mm, invasive to Clark anatomic level
IV. The patient underwent wide local excision of the lesion,
with a negative sentinel node biopsy (Stage IIC, T4N0M0).
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Figure 1: Ultrasound Doppler showing gallbladder mass with high
blood flow.
Figure 2: Surface of resected gallbladder.
Following excision of his facial lesion, he was started on
interferon therapy 5 days a week. A one-month follow-up
included a normal physical exam, normal complete blood
count, and normal complete metabolic panel. Positron emis-
sion tomography (PET-CT) was also obtained at the same
time and was negative for any metastatic lesions.
Threemonths after follow-up, the patient presented to the
hospital with a 3-week history of right upper quadrant (RUQ)
abdominal pain, nausea, alternating bowel movements, and
a 15-pound weight loss. Physical exam revealed RUQ ten-
derness but was otherwise unremarkable. Laboratory test-
ing showed his bilirubin, AST, and ALT to be 0.3mg/dL,
62U/L, and 96U/L, respectively. An abdominal computed
tomography showed a gallbladder lesion. Doppler ultrasound
confirmed a 1.1 × 1 cm gallbladder lesion with high blood flow
(Figure 1). Following this, an ultrasound-guided gallbladder
biopsy was attempted but was unsuccessful because of an
inability to locate the lesion precisely. Due to the high
suspicion of metastasis, the patient underwent a laparo-
scopic cholecystectomy along with a hepatic wedge resection
(Figure 2). This resection revealed no external evidence of
a metastatic gallbladder lesion, both intraoperatively or on
back table inspection. A frozen section of the gallbladder
was also found to be negative for melanoma metastasis.
There was no evidence of pigmentation within the abdomen.
Despite all of this, pathology confirmed the suspicion of
metastatic melanoma of the gallbladder through a positive
Figure 3: Pathology of gallbladder mass showing metastatic
melanoma.
immunohistochemistry stain, showing a BRAFV600Kmuta-
tion (Figure 3). Our operative report justifies the presence of
an intraluminal gallbladder mass, which can be easily missed
on external appearance or on frozen section.
After surgery, the patient did not require adjuvant ther-
apy, such as high-dose interferon or dabrafenib/trametinib,
for his localized metastatic lesion, in accordance with the
most recent guidelines for malignant melanoma [1, 5]. A
follow-up PET-CT was obtained 1 month after surgery and
showed no evidence of the disease recurrence. At the most
recent follow-up, clinic evaluation 6months after surgery, the
patient was well without any evidence of recurrence.
3. Discussion
Melanocytes are a dendritic-type cell, which provides
melanin to keratinocytes and can be found in most organ
viscera, depending on neural crest migration during embryo-
genesis [1, 8]. Melanoma is amalignant tumor ofmelanocytes
and represents <5% of all skin cancers [5, 9]. However, it has
a high potential for widespread metastatic disease and thus is
associated with high mortality.The incidence of melanoma is
growing faster than any other potentially preventable cancer
in the United States with an approximately 1.9 percent growth
annually between 2000 and 2009 [10]. Globally, 132,000 new
cases of melanoma will arise this year with 48,000 deaths per
year [2].
Melanoma usually follows a benign course of early radial
growth. The potential for metastasis greatly increases once
the cutaneous lesion begins to spread vertically, penetrating
blood and lymph vessels [1, 11, 12]. Tumor cells can spread
to the local lymph nodes draining the region of the primary
lesion. It can also travel hematogenously to distant sites,
such as the soft tissues (50–75%), lung (70–87%), liver (54–
77%), and brain [9, 11, 13]. Many authors have also postulated
dissemination of tumor cells via bile, contributing to liver
and GI tract invasion. Only 2–4% of patients affected by
cutaneous melanoma are diagnosed with gastrointestinal
metastases [8]. The most common sites for GI invasion are
the small bowel (35–65%), colon (5–9%), and stomach (5–
7%) [1, 2].
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Cutaneous metastatic melanoma to the gallbladder is
rarely found during a patient’s life [9, 11, 14]. When found,
it usually presents as part of a widespread metastatic disease.
It is important to note that though travel to the gallbladder
is rare, gallbladder melanoma accounts for 50–67% of all
gallbladder tumors [11, 12, 15]. The prognosis is extremely
poor for metastatic gallbladder melanoma with an average
survival of 8.4 months and a 5-year survival of only 15%
[9, 15, 16]. However, the prognosis of metastatic gallbladder
melanoma drastically increases when the gallbladder lesion
is a single focus of metastasis with no other lesions and
is surgically removed [9, 13, 16]. Gallbladder metastases
are relatively asymptomatic, which is why most cases are
discovered during autopsy: Das Gupta et al. conducted an
autopsy study on 125 patients and found that 15% (19 patients)
presented with metastatic lesions to the gallbladder [6, 9, 11,
14]. In rare cases, melanomametastasis to the gallbladder will
present with symptoms such as abdominal pain, as was seen
in our patient, or as an acute cholecystitis [11, 15]. Patient
clinical presentation may include jaundice from obstruction
of the bile duct by the tumor mass, hemobilia, biliary fistulas,
vomiting, nausea, and weight loss [5, 7, 14].
The rarity of the metastasis combined with its asymp-
tomatic nature means the widespread disease has usually
occurred by the time of diagnosis [5, 9, 13]. Addressing this
involves maintaining a high level of suspicion in patients who
present with biliary symptoms and have a known history
of cutaneous melanoma [2, 8]. Doppler ultrasonography
remains to be the method of choice for determining the
presence of a gallbladdermalignancy by detecting high blood
flow regions [7, 13, 15]. In cases of gallbladder melanoma,
ultrasonography will show single or multiple infiltrative
lesions (at least 1 cm in diameter) attached to the inner
mucosal wall [3]. Computed tomography can also be utilized
and has 60–70% sensitivity in detecting metastases [2].
Positron emission tomography can be utilized secondarily
in detecting the extent of spread [1, 2]. Finally, biopsy of
the gallbladder lesion and immunohistochemical staining are
used to confirm the diagnosis [2].
Surgery, as a treatmentmodality formetastaticmelanoma
to the gallbladder, remains questionable since most cases
of gallbladder melanoma are a part of widespread disease
[1]. Metastasectomy remains to be the mainstay approach,
for its palliative and symptom-reducing effects and for cases
of a single localized lesion to the gall bladder like in our
patient [7, 9, 15]. Surgery also functions to prevent further
dissemination from the gallbladder via bile [1]. Dong et al.
found that the 1-year survival in surgically resected patients
can be up to 100%, but without surgery it is documented at
as low as 0% [9]. A liver wedge resection, targeting nearby
regions of the liver pedicle, should also be performed in cases
of probable contiguous spread of neoplastic cells [8].
Management of the patient can also involve chemoim-
munotherapy, especially in the case of a nonlocalized lesion
[1, 2]. Its utility as adjuvant therapy remains unclear [1–3].
Chemoimmunotherapy has garnered recent interest as an
effective treatment modality. Among them is the use of high-
bolus interleukin-2 (IL-2) which has been found to induce
remission in 15% of patients; however, its use is limited due to
toxicity [2, 8]. BRAF inhibitors along with immune therapy
have been utilized in generating an immune response to the
tumors [2, 8]. The use of MEK inhibitors concurrently with
BRAF inhibitors has been shown to lower adverse reactions,
prolong disease-free survival, and delay the resistance that
has been seen in BRAF inhibitor use alone [1].
Melanoma undergoes extensive and rapid growth and
causes widespread damage with very high morbidity and
mortality. We have presented this case to address the need
for a prompt workup with a potential diagnosis of metastasis,
especially in patients with a known history of cutaneous
melanoma. The key to prolonging survival is to consider
metastases early and begin aggressive treatment. Most cases
of gallbladdermetastases present with no symptoms.Workup
should begin with imaging, along with immunohistochem-
ical staining for confirmation. Adequate treatment may
be achieved with laparoscopic cholecystectomies and/or
chemoimmunotherapy.
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